Identification of Latent Diagnostic Biomarkers and Biological Pathways in Dermatomyositis Based on WGCNA

Figure 5

Expression validation of MX2, OAS1, and OAS2. (a) Expression of MX2, OAS1, and OAS2 in the GSE11971 dataset. (b) Expression of MX2, OAS1, and OAS2 in the GSE142807 dataset. (c) Expression of MX2, OAS1, and OAS2 in cell line samples.

(a)

(b)

(c)